One set that was present in their data set after SMARCB1 reactivation and in 2 of our cell lines, CHLA02 and CHLA05, after combination treatment was “WANG_SMARCE1_TARGETS_UP,” which represents genes that are upregulated in breast cancer with reintroduction of SMARCE1, another component of SWI/SNF (Supplementary Fig. 5b). The gene discussed is SMARCE1; the disease is breast carcinoma.